Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.72 $65,761 - $112,733
156,574 Added 29.43%
688,558 $433,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $400,272 - $621,375
381,212 Added 252.84%
531,984 $601,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $172,810 - $393,144
-144,009 Reduced 48.85%
150,772 $204,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $243,928 - $514,959
142,648 Added 93.77%
294,781 $548,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $289,052 - $1.31 Million
152,133 New
152,133 $374,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $1.99 Million - $8.43 Million
-935,112 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $4.43 Million - $11 Million
705,075 Added 306.51%
935,112 $7.45 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $3.38 Million - $6.6 Million
230,037 New
230,037 $3.51 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $7.59 Million - $10.5 Million
-312,185 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $8.91 Million - $13.8 Million
-341,533 Reduced 52.24%
312,185 $10.5 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $7.64 Million - $13.2 Million
-231,118 Reduced 26.12%
653,718 $25 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $25 Million - $36.6 Million
638,343 Added 258.97%
884,836 $37 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $2.62 Million - $4.11 Million
-92,023 Reduced 27.18%
246,493 $10.7 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $3.96 Million - $10.3 Million
338,516 New
338,516 $10.3 Million
Q1 2020

May 14, 2020

SELL
$7.64 - $27.5 $4.42 Million - $15.9 Million
-579,094 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $8.7 Million - $11.9 Million
579,094 New
579,094 $9.34 Million
Q1 2019

May 14, 2019

SELL
$10.65 - $25.75 $7.2 Million - $17.4 Million
-676,015 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $4.07 Million - $7.21 Million
439,916 Added 186.33%
676,015 $7.48 Million
Q3 2018

Nov 14, 2018

SELL
$7.54 - $18.31 $2.26 Million - $5.49 Million
-299,957 Reduced 55.96%
236,099 $3.95 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $2.28 Million - $3.95 Million
468,596 Added 694.63%
536,056 $3.94 Million
Q1 2018

May 15, 2018

SELL
$4.69 - $10.05 $1.64 Million - $3.52 Million
-350,102 Reduced 83.84%
67,460 $316,000
Q4 2017

Feb 14, 2018

SELL
$7.86 - $9.99 $10.3 Million - $13.1 Million
-1,308,720 Reduced 75.81%
417,562 $3.79 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $15.3 Million - $18 Million
1,726,282
1,726,282 $16.2 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.